Pages that link to "Q36534862"
Jump to navigation
Jump to search
The following pages link to Tigecycline: a critical analysis (Q36534862):
Displaying 50 items.
- Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes (Q21132445) (← links)
- Future Challenges And Treatment Of Staphylococcus Aureus Bacteremia With Emphasis On MRSA (Q22305769) (← links)
- Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic (Q24614464) (← links)
- Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections (Q24672937) (← links)
- Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci (Q26853465) (← links)
- Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections (Q28394377) (← links)
- A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia (Q28820781) (← links)
- Tigecycline challenge triggers sRNA production in Salmonella enterica serovar Typhimurium (Q31089832) (← links)
- Looking toward basic science for potential drug discovery targets against community-associated MRSA (Q33560722) (← links)
- Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial (Q33642184) (← links)
- High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria (Q33754471) (← links)
- Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline (Q34133346) (← links)
- A review of tigecycline--the first glycylcycline (Q34602922) (← links)
- Tigecycline: a novel broad-spectrum antimicrobial (Q34630833) (← links)
- Methicillin-resistant Staphylococcus aureus in HIV-infected patients (Q35026548) (← links)
- Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia (Q35564841) (← links)
- Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy (Q35960920) (← links)
- Detection of Clostridium difficile in retail ground meat products in Manitoba (Q36029505) (← links)
- In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia (Q36064268) (← links)
- Multi-targeting by monotherapeutic antibacterials. (Q36679193) (← links)
- In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan (Q36744813) (← links)
- Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner (Q36772071) (← links)
- Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease (Q36887811) (← links)
- Staphylococci. (Q36894458) (← links)
- What is in the pipeline for Gram-negative pathogens? (Q37077619) (← links)
- Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI. (Q37091605) (← links)
- The evaluation and treatment of complicated skin and skin structure infections (Q37111836) (← links)
- Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-pheno (Q37144809) (← links)
- Innocent neonate, resistant staph, and embarrassed staff (Q37192153) (← links)
- Tigecycline: a critical update (Q37233932) (← links)
- Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus (Q37247619) (← links)
- Emergence and management of drug-resistant enterococcal infections (Q37291346) (← links)
- Tigecycline: in community-acquired pneumonia (Q37354127) (← links)
- Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom (Q37413851) (← links)
- Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization (Q37608268) (← links)
- Newer developments in the treatment of Gram-positive infections (Q37636151) (← links)
- Resistant pathogen-associated skin and skin-structure infections: antibiotic options (Q37785546) (← links)
- Vancomycin-resistant enterococcal urinary tract infections (Q37802885) (← links)
- Current state of Clostridium difficile treatment options (Q38023283) (← links)
- The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults (Q38084726) (← links)
- Therapy of Clostridium difficile infection: perspectives on a changing paradigm (Q38139991) (← links)
- Treatment of multidrug-resistant Gram-negative infections in children (Q38185648) (← links)
- Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options). (Q38907793) (← links)
- Tigecycline exerts an antitumoral effect in oral squamous cell carcinoma (Q38920797) (← links)
- Acute generalized exanthematous pustulosis associated with tigecycline (Q40032610) (← links)
- A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells (Q40125605) (← links)
- Diphtheroids-Important Nosocomial Pathogens (Q40329490) (← links)
- Once daily high dose tigecycline - pharmacokinetic/pharmacodynamic based dosing for optimal clinical effectiveness: dosing matters, revisited (Q40423903) (← links)
- ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline (Q40750517) (← links)
- Safety of 48 cases of infection after allogeneic stem cell transplantation treated with tigecycline (Q41035384) (← links)